Aroa Biosurgery
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · New Zealand · 201-500 Employees
View Company Info for Free
Overview
Headquarters
64 Richard Pearse Dr, Auckland, Auckland...Phone Number
+64 98693035Website
www.aroa.comRevenue
$44 MillionStock Symbol
ARXIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
3
1
1
1
1
About Aroa Biosurgery
Aroa Biosurgery, founded in 2008 and formerly known as Mesynthes, is a biotechnology research and development company specializing in medical devices and regenerative tissue products. Based in Auckland, New Zealand with operations in North America, the company develops advanced wound care and surgical solutions. Their product portfolio includes Endoform Dermal Template for chronic non-healing wounds and Reinforced Bioscaffold for ventral hernia repair and abdominal wall reconstruction. Aroa Biosurgery focuses on creating innovative medical solutions that have received FDA clearance and are distributed internationally through strategic partnerships and joint ventures.Explore more
Aroa Biosurgery Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aroa Biosurgery your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Aroa Biosurgery has recently received funding, and reach out quickly before it becomes old news!
Aroa Biosurgery, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Aroa Biosurgery recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Aroa Biosurgery
Product Launch: Get notified when Aroa Biosurgery launches new products
Funding: Get notified immidiatlly once Aroa Biosurgery has new funding data
Check out if Aroa Biosurgery is spiking on competitors!
Click to see if Aroa Biosurgery had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Aroa Biosurgery
Find 2 more new buyers
Company Profile Activity
Activity Insights
Aroa Biosurgery is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Aroa Biosurgery is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Aroa Biosurgery.
Aroa Biosurgery Tech Stack
A closer look at the technologies used by Aroa Biosurgery
See more technologies
Most Recent Scoops
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Hiring Plans
Aroa Biosurgery has more open roles in Engineering & Technical than it has had at any time in the past 12 months with an increased focus that include Medical Device Development, Cross-Functional Collaboration, and Feasibility Studies, and experience with Industrial Design, Medical Device Manufacturing, Prototype Development, and Process Development.
Hiring Plans
Open Position
Hiring Plans
Aroa Biosurgery has more open roles in Operations than it has had at any time in the past 12 months.
Hiring Plans
Open Position
Aroa Biosurgery News & Media
AROA Biosurgery Completes Randomised Controlled Trial for Symphony™; Preliminary Read-Out indicates Primary Endpoint Met
AUCKLAND, New Zealand, March 29, 2026 /PRNewswire/ -- Aroa Biosurgery Limited today announced completion of its randomised controlled trial (RCT) evaluating Symphony, with a preliminary study read-out indicating the trial achieved its primary endpoint. Symphony is AROA's Cellular,...Study demonstrates effectiveness and economic value of Myriad™ in trauma and acute care surgery.
AUCKLAND, New Zealand, Jan. 23, 2026 /PRNewswire/ -- Aroa Biosurgery Limited is pleased to announce that the latest publication from its ongoing prospective study, the Myriad Augmented Soft Tissue Reconstruction Registry (MASTRR), has been published in the Journal of Trauma and Injury. MASTRR is the largest ongoing prospective, multicenter observational study to collect patient data from the use of a bioscaffold in complex reconstruction. To date, over 450 patients have been enrolled. The study,While institutions own 32% of Aroa Biosurgery Limited (ASX:ARX), individual investors are its largest shareholders with 42% ownership
Key Insights Aroa Biosurgery's significant individual investors ownership suggests that the key decisions are...FIRST CLINICAL EVIDENCE PUBLISHED ON AROA's ENIVO™ SYSTEM FOR SURGICAL DEAD SPACE MANAGEMENT.
AUCKLAND, New Zealand, Aug. 27, 2025 /PRNewswire/ -- AROA is pleased to announce the findings of the first in human study involving its new ENIVO platform technology. The study is the subject of a peer-reviewed publication entitled Prospective, First-in-Human Clinical Evaluation of a...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Aroa Biosurgery
Sign Up For FreeTo access detailed company insights
Aroa Biosurgery, founded in 2008 and formerly known as Mesynthes, is a biotechnology research and development company specializing in medical devices and regenerative tissue products. Based in Auckland, New Zealand with operations in North America, the company develops advanced wound care and surgical solutions. Their product portfolio includes End... Read More
